Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Rajasekhara R. Mummadi"'
Autor:
Gloria D. Coronado, Alexandra Kihn-Stang, Matthew T. Slaughter, Amanda F. Petrik, Jamie H. Thompson, Jennifer S. Rivelli, Ricardo Jimenez, Jeffrey Gibbs, Neha Yadav, Rajasekhara R. Mummadi
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Delays in receiving follow-up colonoscopy after an abnormal fecal immunochemical test (FIT) result are associated with increased colorectal cancer incidence and mortality. Little is known about patterns of follow-up colonoscopy co
Externí odkaz:
https://doaj.org/article/05a452ae36194aafb44e2f668d7ee259
Autor:
Carrie M. Nielson, Amanda F. Petrik, Lorie Jacob, William M. Vollmer, Erin M. Keast, Jennifer L. Schneider, Jennifer S. Rivelli, Tanya J. Kapka, Richard T. Meenan, Rajasekhara R. Mummadi, Beverly B. Green, Gloria D. Coronado
Publikováno v:
Cancer Medicine, Vol 7, Iss 9, Pp 4781-4790 (2018)
Abstract Annual fecal immunochemical testing (FIT) is cost‐effective for colorectal cancer (CRC) screening. However, FIT positivity rates and positive predictive value (PPV) can vary substantially, with false‐positive (FP) results adding to colon
Externí odkaz:
https://doaj.org/article/be2b83896d2c46afad26fb1581a31e8f
Autor:
Allison M. Cole, Thuy Vu, Gloria D. Coronado, Eric S. Johnson, Matthew Slaughter, Amanda F. Petrik, Andreea M. Rawlings, Rajasekhara R. Mummadi, Peggy A. Hannon
Publikováno v:
Cancer Epidemiol Biomarkers Prev
Background: Colorectal cancer screening by annual fecal immunochemical test (FIT) with follow-up on abnormal results is a cost-effective strategy to reduce colorectal cancer incidence and mortality. Unfortunately, many patients with abnormal results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf8da7ace42368fc615b8ce4f86c1e69
https://doi.org/10.1158/1055-9965.epi-20-1793
https://doi.org/10.1158/1055-9965.epi-20-1793
Publikováno v:
JAMA. 323:281
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::713ffd7be84080da75343f66b6957c51
https://doi.org/10.1001/jama.2019.18576
https://doi.org/10.1001/jama.2019.18576
Autor:
William M. Vollmer, Erin Keast, Jennifer L. Schneider, Beverly B. Green, Carrie M. Nielson, Gloria D. Coronado, Lorie Jacob, Tanya Kapka, Rajasekhara R. Mummadi, Jennifer S. Rivelli, Amanda F. Petrik, Richard T. Meenan
Publikováno v:
Cancer Medicine, Vol 7, Iss 9, Pp 4781-4790 (2018)
Annual fecal immunochemical testing (FIT) is cost‐effective for colorectal cancer (CRC) screening. However, FIT positivity rates and positive predictive value (PPV) can vary substantially, with false‐positive (FP) results adding to colonoscopy bu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b873a4431eef81cd4b536296dd6ea91b
https://pubmed.ncbi.nlm.nih.gov/30101513
https://pubmed.ncbi.nlm.nih.gov/30101513
Publikováno v:
Transplant International. 23:200-207
Summary Bone mineral density (BMD) loss after liver transplantation (LT) results in considerable morbidity with the increased risk of fractures. Data on the efficacy of bisphosphonate use in post LT patients is scarce. This meta-analysis aims to summ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dec531a448930acae7ff151106e2191
https://doi.org/10.1111/j.1432-2277.2009.00976.x
https://doi.org/10.1111/j.1432-2277.2009.00976.x
Effect of Bariatric Surgery on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
Publikováno v:
Clinical Gastroenterology and Hepatology. 6:1396-1402
Background & Aims Weight loss in overweight or obese individuals results in marked improvement or resolution of hypertension, diabetes mellitus, and hyperlipidemia. However, the overall effect of weight loss on nonalcoholic fatty liver disease (NAFLD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0a3314a33963a9f9129d57ec41519c9
https://doi.org/10.1016/j.cgh.2008.08.012
https://doi.org/10.1016/j.cgh.2008.08.012
Publikováno v:
The American Journal of Medicine. 121:16-18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0f3e27a186db45fedf0f0b625315334
https://doi.org/10.1016/j.amjmed.2007.10.005
https://doi.org/10.1016/j.amjmed.2007.10.005
Hepatotoxicity fears contribute to underutilization of statin medications by primary care physicians
Autor:
Rajasekhara R. Mummadi, Fadi Rzouq, Hilana Hatoum, Michael L. Volk, Gagan Sood, Siva K. Talluri
Publikováno v:
The American journal of the medical sciences. 340(2)
Introduction: The safety and efficacy of hydroxymethylglutaryl CoA reductase inhibitors (statins) have been extensively demonstrated, but in clinical practice, there remains significant underutilization of these medications. The authors hypothesized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baed0112a380fa1e1c54623bb8291972
https://pubmed.ncbi.nlm.nih.gov/20588181
https://pubmed.ncbi.nlm.nih.gov/20588181
Autor:
Praveen Guturu, Ashwani K. Singal, Rajasekhara R. Mummadi, Gagan Sood, Yong Fang Kuo, Amanpal Singh, Sathya Jaganmohan
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 8(2)
Background & Aims The effects of antiviral therapy on prevention of hepatocellular carcinoma (HCC) in patients with hepatitis C virus (HCV)-related cirrhosis are unclear. We performed a systematic review and meta-analysis to assess HCC risk reduction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29e990226c89754ca06feb7e76ba49e0
https://pubmed.ncbi.nlm.nih.gov/19879972
https://pubmed.ncbi.nlm.nih.gov/19879972